Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019

SELL
$78.25 - $107.92 $15,650 - $21,584
-200 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$97.82 - $116.09 $19,564 - $23,218
200 New
200 $20,000
Q2 2018

Aug 13, 2018

SELL
$97.62 - $120.59 $30,750 - $37,985
-315 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$95.91 - $107.26 $2,973 - $3,325
31 Added 10.92%
315 $31,000
Q4 2017

Feb 09, 2018

BUY
$104.5 - $126.38 $29,678 - $35,891
284
284 $30,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.